Amphastar Pharmaceuticals, Inc. (AMPH) › Operating IncomeAmphastar Pharmaceuticals, Inc. (AMPH) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2012: $25.40M2013: $17.49M2014: -$17.98M2015: -$6.90M2016: $15.38M2017: -$1.27M2018: -$8.62M2019: -$39.0K2020: $10.95M2021: $69.89M2022: $107.50M2023: $196.99M2024: $205.42M2025: $140.40M$140.40M2012Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$140.40M-31.7%2024$205.42M+4.3%2023$196.99M+83.2%2022$107.50M+53.8%2021$69.89M+538.0%2020$10.95M+28187.2%2019-$39.0K+99.5%2018-$8.62M-579.5%2017-$1.27M-108.3%2016$15.38M+322.9%2015-$6.90M+61.6%2014-$17.98M-202.8%2013$17.49M-31.1%2012$25.40M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share